EPS

Propelled by its teen-focused Journeys brand, the footwear retailer posted strong profits, navigating mixed results in other divisions and setting a path for 2027.

El Pollo Loco is testing five bold new menu items. We dive into the strategy, the competition, and what it means for the fast-casual chicken wars.

As Concentrix sets its Q1 earnings date, investors are watching closely to see if its AI-driven strategy can overcome market headwinds and cautious guidance.

Investors eye Moody's CEO Rob Fauber's upcoming speech for insights on AI strategy, M&A forecasts, and navigating an increasingly complex global economy.

German defense tech firm RENK Group reports a record €1.37B revenue, fueled by a 24% surge in its defense business amid global geopolitical tensions.

As Jabil preps its Q2 FY26 report, investors watch to see if the AI boom can sustain its momentum amid global economic and supply chain pressures.

As Monro executives prepare for a key investor chat, all eyes are on their strategy for a changing auto market, from store closures to the EV revolution.

Unifi launches Luxel, a new yarn blending linen's feel with performance tech and circular recycling, aiming to redefine sustainable fashion and home goods.

Once a failing firm, Aurelion Inc. bet its future on tokenized gold. The gamble paid off with a profitable quarter, but regulatory risks loom large.

After a strong Q4, Amprius launches a strategic roadshow to pitch its high-energy silicon anode batteries to investors and key aerospace and defense players.

L.E.K. Consulting's new report reveals fierce competition, faster trend cycles, and the widening gap between winners and losers in the apparel industry.

NRG Energy's stock tumbles after it orchestrates a major share sale for a key investor alongside a strategic $300 million buyback, a complex move.

SPIE's acquisition of ROFA Industrial Automation signals a major push into Germany's booming factory and logistics automation market, moving up the value chain.

Colombia's energy giant is set to reveal its 2025 performance, testing its diversification strategy against falling oil prices and high investor expectations.

Zymeworks lands $250M from Royalty Pharma in a non-dilutive deal, validating its cancer drug Ziihera and highlighting a new era of biotech financing.

A $4.4 million inventory write-down plunges the world's first private cord blood bank into the red, raising questions about its public banking model.

Hawaiian Electric Industries reports a dramatic financial turnaround, but the utility's path forward is defined by massive investments in grid safety and renewables.

Nike's rescheduled Q3 earnings report on March 31 amplifies anxiety as the giant battles tariffs, a China slump, and deep market skepticism.

Following a year of stable sales but a reported loss, MTI executives will face investors to outline growth plans in sustainability and advanced materials.

The retail giant announced a 5% dividend increase, a bold move that signals faith in its financial health and strategic pivot in a turbulent market.